Intellectus Partners, LLC Merck & Co., Inc. Transaction History

Intellectus Partners, LLC

$383 Million
Q3 2024

A detailed history of Intellectus Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 6,426 shares of MRK stock, worth $639,065. This represents 0.19% of its overall portfolio holdings.

Number of Shares

6,426

Holding current value

$639,065

% of portfolio

0.19%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$111.15 - $128.97 $714,249 - $828,761	6,426 New	6,426 $729,000
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $15,639 - $17,046	-144 Reduced 1.9%	7,452 $859,000
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $69,278 - $77,300	-673 Reduced 8.14%	7,596 $808,000
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $2,360 - $3,026	-27 Reduced 0.33%	8,269 $917,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $19,272 - $21,650	228 Added 2.83%	8,296 $720,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $3,590 - $4,069	-43 Reduced 0.53%	8,068 $741,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $9,703 - $10,876	-132 Reduced 1.6%	8,111 $671,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $45,030 - $56,406	623 Added 8.18%	8,243 $631,000
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $38,635 - $42,489	539 Added 7.61%	7,620 $577,000
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $908,334 - $1 Million	-12,919 Reduced 64.6%	7,081 $555,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $1.44 Million - $1.59 Million	20,000 New	20,000 $34,000
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $63,414 - $74,083	-908 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $98,969 - $114,852	-1,517 Reduced 62.56%	908 $70,000
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $13,317 - $15,646	-262 Reduced 9.75%	2,425 $148,000
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $18,957 - $22,033	372 Added 16.07%	2,687 $148,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $15,486 - $18,492	-300 Reduced 11.47%	2,315 $131,000
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $9,269 - $9,974	-158 Reduced 5.7%	2,615 $169,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,773	2,773 $179,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Merck & Co., Inc. Transaction History